US Stock MarketDetailed Quotes

SPRB Spruce Biosciences

Watchlist

0.319
-0.004-1.24%

Close Mar 26 16:00 ET

0.319
0.0000.00%

Post 20:01 ET

13.18MMarket Cap-0.34P/E (TTM)

Spruce Biosciences Stock Forum

Trytosaveabit

Feb 21 05:02

Whatchadoin

$Spruce Biosciences (SPRB.US)$ 🤔

Jaguar8

Dec 11, 2024 05:01

NEWS

$Spruce Biosciences (SPRB.US)$
Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH
Tuesday, 10th December at 4:01 pm
CAHmelia-204 Study of 200mg Once-Daily (QD) Tildacerfont in Adult Congenital Adrenal Hyperplasia (CAH) Did Not Achieve Primary Endpoint of Glucocorticoid (GC) Reduction
Dose-Ranging Data from CAHptain-205 Study of Tildacerfont in Adult and Pediatric CAH Suggests Higher Doses and Twice-Daily (BID) Dosing May Be ...

73372627

Aug 11, 2024 02:31

$Zebra Technologies (ZBRA.US)$ and the true of the Spruce analysis

I will never undestend why this company is not investigated for manipulating the market on theirs own interest.
Let's go see why such investigation is neccessary and I hope Zebra will complain.
Spruce it is an Short-selling company which allways made negative reports or analysis in order to influence the market for theyr's own profit. Parallel with Short-selling they are also in real estate managment in New York where they loose b...

Jaguar8

Jun 4, 2024 19:13

NEWS

$Spruce Biosciences (SPRB.US)$
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
Spruce Biosciences (Nasdaq: SPRB) and HMNC Brain Health announced a strategic collaboration to develop a treatment for Major Depressive Disorder (MDD) using Spruce's tildacerfont and HMNC's Cortibon Genetic Selection Tool. The Phase 2 study is set to begin in Q4 2024. Should the study be successful, Spruce has the option to acquire e...